Barchart.com
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Legend Biotech Corp ADR (LEGN)

Legend Biotech Corp ADR (LEGN)
31.85 x 1 33.59 x 3
Post-market by (Cboe BZX)
32.01 -0.87 (-2.65%) 04/04/25 [NASDAQ]
31.85 x 1 33.59 x 3
Post-market 32.01 unch (unch) 16:01 ET
News & Headlines for Fri, Apr 4th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights GlobeNewswire - Tue Mar 11, 6:00AM CDT

LEGN : 32.01 (-2.65%)
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results GlobeNewswire - Tue Feb 25, 7:00AM CST

LEGN : 32.01 (-2.65%)
Oncology Experts Predict 2025 Will Be a Year of Breakthroughs in Treatment and Prevention BayStreet.ca - Wed Jan 22, 8:30AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – One of the largest and most advanced cancer research and treatment organizations in the USA, City of Hope,...

ONCY : 0.4952 (-3.28%)
GH : 40.58 (-3.43%)
LEGN : 32.01 (-2.65%)
PSNL : 3.11 (-5.76%)
GRAL : 22.25 (-10.57%)
ONC.TO : 0.70 (-1.41%)
Legend Biotech CEO to Present Company Updates at 43rd Annual J.P. Morgan Healthcare Conference Quiver Quantitative, Inc. - Thu Dec 19, 2024

Legend Biotech's CEO will present company updates at the J.P. Morgan Healthcare Conference on January 14, 2025.Quiver AI SummaryLegend Biotech Corporation announced that CEO Ying Huang, Ph.D., will present...

LEGN : 32.01 (-2.65%)
Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Thu Dec 19, 2024

LEGN : 32.01 (-2.65%)
Legend Biotech Reports 89% MRD Negativity in CARTITUDE-4 Study for CARVYKTI® in Multiple Myeloma After Three-Year Follow-Up Quiver Quantitative, Inc. - Tue Dec 10, 2024

New data shows CARVYKTI® achieves 89% MRD negativity in multiple myeloma patients, significantly surpassing standard therapies.Quiver AI SummaryLegend Biotech has announced promising results from its...

LEGN : 32.01 (-2.65%)
CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma GlobeNewswire - Mon Dec 9, 2024

LEGN : 32.01 (-2.65%)
Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights GlobeNewswire - Tue Nov 12, 2024

LEGN : 32.01 (-2.65%)
Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition GlobeNewswire - Thu Nov 7, 2024

LEGN : 32.01 (-2.65%)
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma GlobeNewswire - Tue Nov 5, 2024

LEGN : 32.01 (-2.65%)

Barchart Exclusives

How Trump Just Liberated a Massive Discount in Unsung AI Hero Pure Storage (PSTG) Barchart - 11 minutes ago
Although ‘Liberation Day’ has been chaotic for the tech ecosystem, the core fundamentals arguably remain incredibly attractive for PSTG stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot